Synaptic vesicle protein 2A (SV2A) drugs for Focal Onset Seizures

2 tracked Synaptic vesicle protein 2A (SV2A) drugs in the Focal Onset Seizures race. The class explanation lives on the Synaptic vesicle protein 2A (SV2A) page; the full indication pipeline across every mechanism is on the Focal Onset Seizures page.

2 approved / phase 4

Head-to-head evidence: Levetiracetam (Keppra) vs Levetiracetam (Keppra XR)

The roster

← all Synaptic vesicle protein 2A (SV2A) drugs